Stay updated on Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial
Sign up to get notified when there's something new on the Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial page.

Latest updates to the Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check34 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.9%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check77 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of imetelstat for myelofibrosis, while adding new identifiers and a revision update.SummaryDifference14%
- Check84 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imetelstat Activity in JAK-Inhibitor-Treated MF Clinical Trial page.